Search Results - "Mamauag, Marlie Jane"
-
1
Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation
Published in Frontiers in endocrinology (Lausanne) (19-04-2022)“…Primary aldosteronism (PA) is the most common cause of secondary hypertension, and patients are at an increased risk of atrial fibrillation (AF) and stroke. We…”
Get full text
Journal Article -
2
Central pontine myelinolysis: a rare presentation secondary to hyperglycaemia
Published in Singapore medical journal (01-04-2015)“…Central pontine myelinolysis (CPM) is classically described as a demyelinating condition that results from the rapid correction of hyponatraemia. CPM has also…”
Get full text
Journal Article -
3
Effects of MLC601 on Early Vascular Events in Patients After Stroke: The CHIMES Study
Published in Stroke (1970) (01-12-2013)“…BACKGROUND AND PURPOSE—Early vascular events are an important cause of morbidity and mortality in the first 3 months after a stroke. We aimed to investigate…”
Get full text
Journal Article -
4
Comparison Between the Original and Shortened Versions of the National Institutes of Health Stroke Scale in Ischemic Stroke Patients of Intermediate Severity
Published in Stroke (1970) (01-01-2016)“…BACKGROUND AND PURPOSE—The 15-item National Institutes of Health Stroke Scale (NIHSS) has been critiqued for its complexity and variability, and shortened…”
Get full text
Journal Article -
5
Durability of the beneficial effect of MLC601 (NeuroAiD™) on functional recovery among stroke patients from the Philippines in the CHIMES and CHIMES-E studies
Published in International journal of stroke (01-04-2017)“…Background and Aim A pre-specified country analysis of subjects from the Philippines in the CHInese Medicine NeuroAiD Efficacy on Stroke recovery (CHIMES)…”
Get full text
Journal Article -
6
Baseline Characteristics and Treatment Response of Patients from the Philippines in the CHIMES Study
Published in International journal of stroke (01-10-2014)“…Background The CHIMES Study compared MLC601 with placebo in patients with ischemic stroke of intermediate severity in the preceding 72 h. Sites from the…”
Get full text
Journal Article